Five-year local control in a phase II study of hypofractionated intensity modulated radiation therapy with an incorporated boost for early stage breast cancer

International Journal of Radiation Oncology Biology Physics

Volumn 84, Issue 4, 2012, Pages 888-893

  Freedman, Gary M ^a   Anderson, Penny R ^b   Bleicher, Richard J ^b   Litwin, Samuel ^b   Li, Tianyu ^b   Swaby, Ramona F ^b   Ma, Chang Ming Charlie ^b   Li, Jinsheng ^b   Sigurdson, Elin R ^b   Watkins Bruner, Deborah ^c   Morrow, Monica ^d   Goldstein, Lori J ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b FOX CHASE CANCER CENTER   (United States)

^c EMORY UNIVERSITY   (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Breast boost; Breast cancer; Hypofractionation; IMRT; Radiation therapy

Indexed keywords

CHEMOTHERAPY; DISEASES; PATIENT TREATMENT; TUMORS;

BREAST BOOST; BREAST CANCER; DUCTAL CARCINOMA IN SITU; EARLY-STAGE BREAST CANCER; HYPOFRACTIONATION; IMRT; INTENSITY-MODULATED RADIATION THERAPY; METHODS AND MATERIALS;

RADIOTHERAPY;

CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; PACLITAXEL; TRASTUZUMAB;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLADDER CANCER; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CARCINOMA IN SITU; COLON CANCER; COMORBIDITY; ENDOMETRIUM CANCER; FEMALE; FOLLOW UP; HUMAN; INTENSITY MODULATED RADIATION THERAPY; INTRADUCTAL CARCINOMA; LIVER CELL CARCINOMA; LOCAL RECURRENCE FREE SURVIVAL; LUNG CANCER; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MELANOMA; MULTIMODALITY CANCER THERAPY; OVARY CANCER; PARTIAL MASTECTOMY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION DERMATITIS; RADIATION DOSE FRACTIONATION; RECURRENCE RISK; SKIN CARCINOMA; SYSTEMIC THERAPY; TREATMENT DURATION; TREATMENT OUTCOME; TUMOR VOLUME; BREAST TUMOR; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PHOTON; RADIATION EXPOSURE; SECOND CANCER; SEGMENTAL MASTECTOMY; SKIN; TIME; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA IN SITU; COMBINED MODALITY THERAPY; DOSE FRACTIONATION; FEMALE; HUMANS; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASMS, SECOND PRIMARY; PHOTONS; QUALITY OF LIFE; RADIOTHERAPY, INTENSITY-MODULATED; SKIN; TIME FACTORS; TUMOR BURDEN;

EID: 84872012344     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2012.01.091     Document Type: Article

References (30)

1. National Comprehensive Cancer Network. NCCN practice guidelines for breast cancer. Version 1 2012. Available at: http://www.nccn.org/professionals/ physician-gls/PDF/breast.pdf. Accessed Jan. 1, 2012.
2. National Institutes of Health Consensus Conference. Treatment of early-stage breast cancer. JAMA 1991; 265:391-395.
3. Early Breast Cancer Trialists' Collaborative Group. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005; 366:2087-2106.
4. Lazovich D, Solomon CC, Thomas DB, et al. Breast conservation therapy in the United States following the 1990 National Institutes of Health Consensus Development Conference on the treatment of patients with early stage invasive breast carcinoma. Cancer 1999; 86: 628-637.
5. Morrow M, White J, Moughan J, et al. Factors predicting the use of breast-conserving therapy in stage I and II breast carcinoma. J Clin Oncol 2001; 19:2254-2262.
6. Polednak AP. Trends in, and predictors of, breast-conserving surgery and radiotherapy for breast cancer in Connecticut, 1988-1997. Int J Radiat Oncol Biol Phys 2002; 53:157-163.
7. Freedman GM, Anderson PR, Goldstein LJ, et al. Four-week course of radiation for breast cancer using hypofractionated intensity modulated radiation therapy with an incorporated boost. Int J Radiat Oncol Biol Phys 2007; 68:347-353.
8. American Joint Committee on Cancer. AJCC Cancer Staging Manual. 5th ed. Philadelphia: Lippincott-Raven; 1997.
9. Li J, Freedman G, Price R, et al. Clinical implementation of intensity-modulated tangential beam irradiation for breast cancer. Med Phys 2004; 31:1023-1031.
10. National Cancer Institute Cancer Therapy Evaluation Program. Common terminology criteria for adverse events. Available at: http://ctep.cancer.gov/ protocolDevelopment/electronic-applications/docs/ctcaev3.pdf. Accessed April 26, 2012.
11. Aaronson NK, Bartelink H, van Dongen J, et al. Evaluation of breast conserving therapy: clinical, methodological and psychosocial perspectives. Eur J Surg Oncol 1988; 14:133-140.
12. Stanton AL, Krishnan L, Collins CA. Form or function? Part 1. Subjective cosmetic and functional correlates of quality of life in women treated with breast-conserving surgical procedures and radiotherapy. Cancer 2001; 91:2273-2281.
13. Krishnan L, Stanton AL, Collins CA, et al. Form or function? Part 2. Objective cosmetic and functional correlates of quality of life in women treated with breast-conserving surgical procedures and radiotherapy. Cancer 2001; 91:2282-2287.
14. Yarnold J, Ashton A, Bliss J, et al. Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: long-term results of a randomised trial. Radiother Oncol 2005; 75:9-17.
15. Owen JR, Ashton A, Bliss JM, et al. Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: long-term results of a randomised trial. Lancet Oncol 2006; 7:467-471.
16. START Trialists' Group. The UK standardisation of breast radiotherapy (START) trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet Oncol 2008; 9: 331-341.
17. START Trialists' Group. The UK standardisation of breast radiotherapy (START) trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet 2008; 371: 1098-1107.
18. Whelan TJ, Pignol J-P, Levine MN, et al. Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med 2010; 362:513-520.
19. Whelen T, MacKenzie R, Julian J, et al. Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancer. J. Natl Cancer Inst 2002; 94:1143-1150.
20. Romestaing P, Lehingue Y, Carrie C, et al. Role of a 10-Gy boost in the conservative treatment of early breast cancer: results of a randomized clinical trial in Lyon, France. J Clin Oncol 1997; 15:963-968.
21. Bartelink H, Horiot J-C, Poortmans PM, et al. Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial. J Clin Oncol 2007; 25:3259-3265.
22. Ceilley E, Jagsi R, Goldberg S, et al. Radiotherapy for invasive breast cancer in North America and Europe: results of a survey. Int J Radiat Oncol Biol Phys 2005; 61:365-373.
23. Formenti SC, Gidea-Addeo D, Goldberg JD, et al. Phase I-II trial of prone accelerated intensity modulated radiation therapy to the breast to optimally spare normal tissue. J Clin Oncol 2007; 25:2236-2242.
24. Chadha M, Woode R, Sillanpaa J, et al. Results using 3-week accelerated whole-breast (WB) radiation therapy (RT) and concomitant boost for early-stage node negative breast cancer. Int J Radiat Oncol Biol Phys 2009; 75:S77.
25. Fowble B, Hanlon A, Freedman G, et al. Second cancers after conservative surgery and radiation for stages I-II breast cancer: identifying a subset of women at increased risk. Int J Radiat Oncol Biol Phys 2001; 51:679-690.
26. Li JS, Freedman GM, Price R, et al. Clinical implementation of intensity-modulated tangential beam irradiation for breast cancer. Med Phys 2004; 31:1023-1031.
27. Chui C, Hong L, Hunt M, et al. A simplified intensity modulated radiation therapy technique for the breast. Med Phys 2002; 29:522-529.
28. Donovan E, Bleakley N, Denholm E, et al. Randomised trial of standard 2D radiotherapy (RT) versus intensity modulated radiotherapy (IMRT) in patients prescribed breast radiotherapy. Radiother Oncol 2007; 82:254-264.
29. Pignol JP, Olivotto I, Rakovitch E, et al. A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis. J Clin Oncol 2008; 26:2085-2092.
30. Freedman G, Li T, Nicolaou N, et al. Breast intensity modulated radiation therapy reduces time spent with acute dermatitis for women of all breast sizes during radiation. Int J Radiat Oncol Biol Phys 2009; 74:689-694.